Concert Pharmaceuticals to Participate in Fireside Chat at The JMP Securities Life Sciences Conference
09 Junho 2022 - 8:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will participate in a fireside chat at The JMP Securities
Life Sciences Conference on June 16, 2022 at 1:00 p.m. ET in New
York, NY.
A webcast of the JMP fireside chat may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. A replay of the webcast will be available on
Concert’s website for two weeks following the presentation.
About Concert
Concert Pharmaceuticals is a clinical stage biopharmaceutical
company that is developing small molecule drugs that it discovered
through the application of its DCE Platform® (deuterated chemical
entity platform). Selective incorporation of deuterium into known
molecules has the potential, on a case-by-case basis, to provide
better pharmacokinetic or metabolic properties, thereby enhancing
their clinical safety, tolerability or efficacy. Concert’s lead
product candidate is in late-stage development for the treatment of
alopecia areata, a serious autoimmune dermatological condition.
Concert is also assessing a number of earlier-stage pipeline
candidates. For more information please visit www.concertpharma.com
or follow us on Twitter at @ConcertPharma or on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220609005071/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
Notícias em tempo-real sobre Concert Pharmaceuticals Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Concert Pharmaceuticals Inc